1001 related articles for article (PubMed ID: 17721194)
1. Diagnostic utility of WT1 immunostaining in ovarian sertoli cell tumor.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Sep; 31(9):1378-86. PubMed ID: 17721194
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of alternative and traditional immunohistochemical markers for the distinction of ovarian sertoli cell tumor from endometrioid tumors and carcinoid tumor: A study of 160 cases.
Zhao C; Bratthauer GL; Barner R; Vang R
Am J Surg Pathol; 2007 Feb; 31(2):255-66. PubMed ID: 17255771
[TBL] [Abstract][Full Text] [Related]
3. Identification of the most sensitive and robust immunohistochemical markers in different categories of ovarian sex cord-stromal tumors.
Zhao C; Vinh TN; McManus K; Dabbs D; Barner R; Vang R
Am J Surg Pathol; 2009 Mar; 33(3):354-66. PubMed ID: 19033865
[TBL] [Abstract][Full Text] [Related]
4. The utility of calretinin, inhibin, and WT1 immunohistochemical staining in the differential diagnosis of ovarian tumors.
Cathro HP; Stoler MH
Hum Pathol; 2005 Feb; 36(2):195-201. PubMed ID: 15754297
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of sox9 in ovarian Sertoli cell tumors and other tumors in the differential diagnosis.
Zhao C; Bratthauer GL; Barner R; Vang R
Int J Gynecol Pathol; 2007 Jan; 26(1):1-9. PubMed ID: 17197889
[TBL] [Abstract][Full Text] [Related]
6. SF-1 is a diagnostically useful immunohistochemical marker and comparable to other sex cord-stromal tumor markers for the differential diagnosis of ovarian sertoli cell tumor.
Zhao C; Barner R; Vinh TN; McManus K; Dabbs D; Vang R
Int J Gynecol Pathol; 2008 Oct; 27(4):507-14. PubMed ID: 18753972
[TBL] [Abstract][Full Text] [Related]
7. Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases.
Ordi J; Schammel DP; Rasekh L; Tavassoli FA
Mod Pathol; 1999 Oct; 12(10):933-40. PubMed ID: 10530556
[TBL] [Abstract][Full Text] [Related]
8. Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin.
Deavers MT; Malpica A; Liu J; Broaddus R; Silva EG
Mod Pathol; 2003 Jun; 16(6):584-90. PubMed ID: 12808064
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor alpha and progesterone receptor expression in ovarian adult granulosa cell tumors and Sertoli-Leydig cell tumors.
Farinola MA; Gown AM; Judson K; Ronnett BM; Barry TS; Movahedi-Lankarani S; Vang R
Int J Gynecol Pathol; 2007 Oct; 26(4):375-82. PubMed ID: 17885486
[TBL] [Abstract][Full Text] [Related]
10. Ovarian sertoli-leydig cell tumors with pseudoendometrioid tubules (pseudoendometrioid sertoli-leydig cell tumors).
McCluggage WG; Young RH
Am J Surg Pathol; 2007 Apr; 31(4):592-7. PubMed ID: 17414107
[TBL] [Abstract][Full Text] [Related]
11. Sex cord-stromal tumors of the ovary and testis: their similarities and differences with consideration of selected problems.
Young RH
Mod Pathol; 2005 Feb; 18 Suppl 2():S81-98. PubMed ID: 15502809
[TBL] [Abstract][Full Text] [Related]
12. CD56 is a sensitive and diagnostically useful immunohistochemical marker of ovarian sex cord-stromal tumors.
McCluggage WG; McKenna M; McBride HA
Int J Gynecol Pathol; 2007 Jul; 26(3):322-7. PubMed ID: 17581419
[TBL] [Abstract][Full Text] [Related]
13. FOXL2 is a sensitive and specific marker for sex cord-stromal tumors of the ovary.
Al-Agha OM; Huwait HF; Chow C; Yang W; Senz J; Kalloger SE; Huntsman DG; Young RH; Gilks CB
Am J Surg Pathol; 2011 Apr; 35(4):484-94. PubMed ID: 21378549
[TBL] [Abstract][Full Text] [Related]
14. Inhibin expression in ovarian tumors and tumor-like lesions: an immunohistochemical study.
Kommoss F; Oliva E; Bhan AK; Young RH; Scully RE
Mod Pathol; 1998 Jul; 11(7):656-64. PubMed ID: 9688187
[TBL] [Abstract][Full Text] [Related]
15. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
[TBL] [Abstract][Full Text] [Related]
16. Sertoliform endometrioid carcinoma of the endometrium with dual immunophenotypes for epithelial membrane antigen and inhibin alpha: case report and literature review.
Liang SX; Patel K; Pearl M; Liu J; Zheng W; Tornos C
Int J Gynecol Pathol; 2007 Jul; 26(3):291-7. PubMed ID: 17581414
[TBL] [Abstract][Full Text] [Related]
17. Inhibin alpha and beta expression in ovarian stromal tumors and their histological equivalences.
Ciriş M; Erhan Y; Zekioglu O; Bayramoglu H
Acta Obstet Gynecol Scand; 2004 May; 83(5):491-6. PubMed ID: 15059165
[TBL] [Abstract][Full Text] [Related]
18. CD10 expression in pure stromal and sex cord-stromal tumors of the ovary: an immunohistochemical analysis of 101 cases.
Oliva E; Garcia-Miralles N; Vu Q; Young RH
Int J Gynecol Pathol; 2007 Oct; 26(4):359-67. PubMed ID: 17885484
[TBL] [Abstract][Full Text] [Related]
19. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
20. Morphologic spectrum of immunohistochemically characterized clear cell carcinoma of the ovary: a study of 155 cases.
DeLair D; Oliva E; Köbel M; Macias A; Gilks CB; Soslow RA
Am J Surg Pathol; 2011 Jan; 35(1):36-44. PubMed ID: 21164285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
